References

1. Ahmed AA, Nordlind K, Schultzberg M, Liden S (1994) Interleukin-1 alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunore-activities in chronic granulomatous skin conditions. Acta Derm Venereol 74:435-440

2. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511

3. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG (2001) Expression of the peptide antibiotics human beta defensin-1 and human beta de-fensin-2 in normal human skin. J Invest Dermatol 117:106-111

4. Baker BS, Ovigne JM, Powles AV, Corcoran S, Fry L (2003) Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 148:670-679

5. Barker JN, Mitra RS, Griffits CE, Dixit VM, Nick-oloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337:211-214

6. Barker JN, Jones ML, Mitra RS, Crockett-Torabe E, Fantone JC, Kunkel SL, Warren JS, Dixit VM, Nick-oloff BJ (1991) Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139:869-876

7. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029

8. Boer J, Weltevreden EF (1996) Hidradenitis suppu-rativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol 135:721-725

9. Chadebech P, Goidin D, Jacquet C, Viac J, Schmitt D, Staquet MJ (2003) Use of human reconstructed epidermis to analyze the regulation of beta-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS. Cell Biol Toxicol 19:313-324

10. Chiller K, Selkin BA, Murakawa GJ (2001) Skin microflora and bacterial infections of the skin. J Invest Dermatol Symp Proc 6:170-174

11. Chung WO, Dale BA (2004) Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 72:352-358

12. Curry JL, Qin JZ, Bonish B, Carrick R, Bacon P, Panella J, Robinson J, Nickoloff BJ (2003) Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 127:178-186

13. Dinulos JG, Mentele L, Fredericks LP, Dale BA, Darmstadt GL (2003) Keratinocyte expression of human beta defensin 2 following bacterial infection: role in cutaneous host defense. Clin Diagn Lab Immunol 10:161-166

14. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gud-mundsson GH, Gallo RL (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-97

15. Dvorak VC, Root RK, MacGregor RR (1977) Host defense mechanisms in hidradenitis suppurativa. Arch Dermatol 113:450-453

16. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S (1997) Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 158:3285-3292

17. Frohm M, Agerberth B, Ahangari G, Stahle-Back-dahl M, Liden S, Wigzell H, Gudmundsson GH (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human ke-ratinocytes during inflammatory disorders. J Biol Chem 272:15258-15263

18. Fukao T, Koyasu S (2003) PI3K and negative regulation of TLR signaling. Trends Immunol 24:358-363

19. Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I (1998) RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratino-cytes by active vitamin D3 (tacalcitol). Br J Derma-tol 138:63-70

20. Fulton C, Anderson GM, ZasloffM, Bull R, Quinn AG (1997) Expression of natural peptide antibiotics in human skin. Lancet 350:1750-1751

21. Gallo RL, Huttner KM (1998) Antimicrobial pep-tides: an emerging concept in cutaneous biology. J Invest Dermatol 111:739-743

22. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B (2005) A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immunity 73:4512-4521

23. Gillitzer R, Wolff K, Tong D, Muller C, Yoshimura T, Hartmann AA, Stingl G, Berger R (1993) MCP-1 mRNA expression in basal keratinocytes of psori-atic lesions. J Invest Dermatol 101:127-131

24. Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, Girolomoni G, Pastore S (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cy-tokines. J Allergy Clin Immunol 107:871-877

25. Harder J, Schroder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779-46784

26. Harder J, Bartels J, Christophers E, Schroder JM (1997) A peptide antibiotic from human skin. Nature 387:861

27. Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-5713

28. Harder J, Meyer-Hoffert U, Wehkamp K, Schwich-tenberg L, Schroder JM (2004) Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123:522-529

29. Heilborn JD, Nilsson MF, Kratz G, Weber G, So-rensen O, Borregaard N, Stahle-Backdahl M (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120:379-389

30. Hieshima K, Ohtani H, Shibano M, Izawa D, Na-kayama T, Kawasaki Y, Shiba F, Shiota M, Ka-tou F, Saito T, Yoshie O (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 170:452-1461

31. Homey B, Bunemann E (2004) Chemokines and inflammatory skin diseases. Ernst Schering Res Found Workshop 45:69-83

32. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8:157-165

33. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216

34. Jansen I, Altmeyer P, Plewig G (2001) Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol 15:532-540

35. Jemec GB, Faber M, Gutschik E, Wendelboe P (1996) The bacteriology of hidradenitis suppurativa. Dermatology 193:203-206

36. Kawai K, Shimura H, Minagawa M, Ito A, Tomi-yama K, Ito M (2002) Expression of functional Tolllike receptor 2 on human epidermal keratinocytes. J Dermatol Sci 30:185-194

37. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uemat-su S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169:1535-1541

38. Kis K, Koreck A, Szegedi K, Dioszegi C, Paunescu V, Cioaca R, Olariu R, Kemeny L, Szell M (2005) Polymorphisms of interleukin-1 receptor antagonist, Toll-like Receptor 2 and 4 genes in patients with acne. ESDR abstract reference number: E0349

39. Kopp E, Medzhitov R (2002) Skin antibiotics get in the loop. Nat Med 8:1359-1360

40. Koreck A, Pivarcsi A, Dobozy A, Kemeny L (2003) The role of innate immunity in the pathogenesis of acne. Dermatology 206:96-105

41. Lapins J, Jarstrand C, Emtestam L (1999) Coagu-lase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140:9095

42. Lapins J, Asman B, Gustafsson A, Bergstrom K, Emtestam L (2001) Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm Venereol 81:96-99

43. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63:1291-1297

44. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T (2002) Human beta-defensin-2 production in keratinocytes is regulated by inter-leukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275-281

45. Liu L, Zhou X, Shi J, Xie X, Yuan Z (2003) Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin. Immunology 110:341-347

46. Marzano AV, Mercogliano M, Borghi A, Facchetti M, Caputo R (2003) Cutaneous infection caused by Salmonella typhi. J Eur Acad Dermatol Venereol 17:575-577

47. Matsubara M, Harada D, Manabe H, Hasegawa K (2004) Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratino-cytes via mitogen-activated protein kinases. FEBS Lett 566:195-200

48. McDaniel DH, Welton WA (1984) Furunculosis and hidradenitis suppurativa response. Arch Dermatol 120:437

49. Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococ-cus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121:1389-1396

50. Mercurio F, Manning AM (1999) Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 11:226-232

51. Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M (2003) Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71:3730-3739

52. Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL (2002) Cathelicidin anti-micro-bial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119:1090— 1095

53. Murphy JE, Robert C, Kupper TS (2000) Interleu-kin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 114:602-608

54. Nagy I, Pivarcsi A, Koreck A, Szell M, Urban E, Kemeny L (2005) Distinct strains of Propionibacterium acnes induces selective human ß-defensin-2 and interleukin-8 expression in human keratino-cytes through Toll-like receptors. J Invest Dermatol 124:931-938

55. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457

56. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I (2002) A catheli-cidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:2026

57. Oren A, Ganz T, Liu L, Meerloo T (2003) In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74:180-182

58. Otte JM, Cario E, Podolsky DK (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gas-troenterology 126:1054-1070

59. Pivarcsi A, Bodai L, Rethi B, Kenderessy-Szabo A, Koreck A, Szell M, Beer Z, Bata-Csorgoo Z, Magocsi M, Rajnavolgyi E, Dobozy A, Kemeny L (2003) Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15:721-730

60. Pivarcsi A, Koreck A, Bodai L, Szell M, Szeg C, Belso N, Kenderessy-Szabo A, Bata-Csorgo Z, Dobozy A, Kemeny L (2004) Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes. Arch Dermatol Res 296:120-124

61. Pivarcsi A, Nagy I, Kemeny L (2005) Innate immunity of the skin: how keratinocytes fight against pathogens. Curr Immunol Rev 1:29-42

62. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241

63. Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB (1999) Upregulation of RANTES inpsoriatic keratinocytes: apossiblepatho-genic mechanism for psoriasis. Acta Derm Venereol 79:9-11

64. Schroder JM, Harder J (1999) Human beta-defen-sin-2. Int J Biochem Cell Biol 31:645-651

65. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189:1777-1782

66. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC (2002) Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 119:424-432

67. Strober W (2004) Epithelial cells pay a Toll for protection. Nat Med 10:898-900

68. Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, Akira S (2003) Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 47:327-336

69. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16:3-9

70. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335-376

71. Wedi B, Kapp A (2002) Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Der-matol 3:273-282

72. Wiedow O, Harder J, Bartels J, Streit V, Christophers E (1998) Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratino-cytes. Biochem Biophys Res Commun 248:904-909

73. Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34:204-209

74. Wollina U, Kunkel W, Bulling L, Funfstuck C, Knoll B, Vennewald I, Hipler UC (2004) Candida albicans-induced inflammatory response in human keratinocytes. Mycoses 47:193-199

75. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168:348-355

76. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, Segal DM, Duff GW, Dower SK (2000) Evidence for an accessory protein function for Tolllike receptor 1 in anti-bacterial responses. J Immunol 165:7125-7132

77. Yang D, Chen Q, Chertov O, Oppenheim JJ (2000) Human neutrophil defensins selectively chemoat-tract naive T and immature dendritic cells. J Leukoc Biol 68:9-14

78. Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23:291-296

79. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ (2003) Many chemo-kines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448-455

80. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528

81. Zhang G, Ghosh S (2001) Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13-19

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment